Extracorporeal heterospleen (splenic sorption) reduced intensive care time by 1.5 times and mortality by 33% in patients with myasthenia and Guillain-Barré syndrome. This treatment removes autoimmune factors, aiding nervous system recovery.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: